The bipartisan Cancer Drug Parity Act would prevent insurers from imposing higher out-of-pocket costs, deductibles, copayments, or coinsurance for oral and patient-administered cancer medications than for treatments administered in a hospital or clinic.

We need your help encouraging senators to act.

Please contact your legislators today and ask them to support the Cancer Drug Parity Act (H.R. 4101/S. 5004) and become cosponsors.

We encourage you to add a brief personal story about how metastatic breast cancer or the cost of cancer treatment has affected you or someone you love. Personal stories help lawmakers understand the real-world consequences of unequal insurance coverage.

Oral cancer treatments are an increasingly common standard of care, and many have no intravenous or injectable equivalent. Yet differences in insurance coverage can leave patients facing significantly higher costs for the treatment their healthcare providers recommend.

Treatment decisions should be based on medical need—not the way an insurance plan classifies a medication.

Please take action today and ask your representatives and senators to co-sponsor the Cancer Drug Parity Act.

Thank you for using your voice on behalf of people living with metastatic breast cancer.